Integra Therapeutics closes a €10.7 million funding round, with participation from Columbus, EIC Fund, CDTI, Invivo, Takeda, and AdBio

by CDTI Innovación

The funds will be used to incorporate new advances into the FiCAT gene writing platform, validate various next generation CAR-T therapies in the preclinical phase and expand the FiCAT cell engineering...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

IMAP has closed 141 transactions in 2026...

by Albia Capital Partners

Global M&A activity remained resilient during the first half of 2026, ...

Photos Stream